Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells.
Rizzo MT
Cancer Res. 59(19):5047-53.
In vitro growth of mobilized peripheral blood progenitor cells is significantly enhanced by stem cell factor.
Cesana C
Stem Cells. 15(3):207-13.
Identification of Philadelphia-negative granulocyte-macrophage colony-forming units generated by stroma-adherent cells from chronic myelogenous leukemia patients.
Carlo-Stella C
Blood. 83(5):1373-80.
In vitro marrow purging in chronic myelogenous leukemia: effect of mafosfamide and recombinant granulocyte–macrophage colony-stimulating factor.
Carlo-Stella C
Bone Marrow Transplant. 8(4):265-73.
In vitro and in vivo effects of recombinant interferon gamma on the growth of hematopoietic progenitor cells from patients with myelodysplastic syndrome.
Rosti V
Haematologica. 74(5):435-40.
In vitro growth of bone marrow-derived multipotent and lineage-restricted hematopoietic progenitor cells in myelodysplastic syndromes.
Carlo-Stella C
Haematologica. 74(2):181-6.
IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis.
Galluzzo M
Dermatology. 2015 Dec 18;232(2):230-6. doi: 10.1159/000441719
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes.
Bernard E
Nat Med. 2020 Aug 3;26(10):1549-1556. doi: 10.1038/s41591-020-1008-z
Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity.
Anfray C
J Immunother Cancer. 9(9)doi: 10.1136/jitc-2021-002408
Integration of retroviral vectors induces minor changes in the transcriptional activity of T cells from ADA-SCID patients treated with gene therapy.
Cassani B
Blood. 2009 Aug 3;114(17):3546-56. doi: 10.1182/blood-2009-02-202085